Nothing found

Latest Articles

• 

  Introducing Mundus Mini HD by EQUASHIELD: Redefining the Safe Handling of Hazardous Drugs

  December 1, 2023 Comments Off on Introducing Mundus Mini HD by EQUASHIELD: Redefining the Safe Handling of Hazardous Drugs

  The Next Generation in Safe, Efficient, and High-Quality Automated Compounding of Hazardous Drugs PORT WASHINGTON, N.Y., Dec. 1, 2023 /PRNewswire/ — EQUASHIELD, a leading innovator in the field of Closed System Transfer Devices (CSTD) and [...]

• 

  ARCH-allied AN Venture Partners raises $200M to build biotechs out of research from Japan

  December 1, 2023 Comments Off on ARCH-allied AN Venture Partners raises $200M to build biotechs out of research from Japan

• 

  Potrero Medical Announces Restructuring and Continued Operations

  December 1, 2023 Comments Off on Potrero Medical Announces Restructuring and Continued Operations

• 

  Scrum Studio and Hakuhodo Launch AgeTechX to Redefine the Future of Health and Longevity

  December 1, 2023 Comments Off on Scrum Studio and Hakuhodo Launch AgeTechX to Redefine the Future of Health and Longevity

• 

  280Bio doses first patient in Phase I clinical trial of TEB-17231, an oral pan-RAS inhibitor in patients with advanced cancers harboring mutations in KRAS, HRAS, or NRAS

  December 1, 2023 Comments Off on 280Bio doses first patient in Phase I clinical trial of TEB-17231, an oral pan-RAS inhibitor in patients with advanced cancers harboring mutations in KRAS, HRAS, or NRAS